A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, necessitates rapid and accurate diagnostic tools.
• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) is standard but has limitations in speed and sensitivity.
• Urgent need exists for faster, highly sensitive SARS-CoV-2 detection methods.

Purpose of the Study:

• To develop a rapid and highly sensitive diagnostic platform for SARS-CoV-2 detection.
• To combine isothermal amplification and fluorescence detection for improved diagnostics.
• To create an automated recombinase polymerase amplification (RPA)-fluorescence system.

Main Methods:

• Developed an auto-recombinase polymerase amplification (RPA)-fluorescence platform.
• Optimized primers and probes for enhanced detection.
• Integrated isothermal amplification with real-time fluorescence detection.

Main Results:

• The RPA platform detected SARS-CoV-2 nucleic acids in 15 minutes.
• Achieved a limit of detection of 5 copies/µL.
• Demonstrated 100% specificity and 100% accuracy in detecting 16 positive samples.

Conclusions:

• The developed RPA-fluorescence platform shows potential for rapid SARS-CoV-2 diagnosis.
• This technology offers a promising alternative to current qRT-PCR methods.
• The platform provides a sensitive, specific, and accurate tool for COVID-19 detection.